Usha Soundarapandian, MD
Family Medicine · Roanoke, VANPI 1154581411
Payments from drug & device makers
Across 136 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$760
- Lilly USA, LLC$294
- AbbVie$276
- Exact Sciences$173
- Amarin Pharma, Inc.$172
- AstraZeneca$137
- plus $473 from 14 others
What the payments were for
- Food & beverage$2,283100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $760 |
| Lilly USA, LLC | 19 | $294 |
| AbbVie(2 entities) | 13 | $276 |
| Exact Sciences | 9 | $173 |
| Amarin Pharma, Inc. | 10 | $172 |
| AstraZeneca | 9 | $137 |
| Dexcom, Inc. | 5 | $97 |
| Amgen | 2 | $57 |
| Grifols USA, LLC | 2 | $52 |
| Boehringer Ingelheim | 2 | $51 |
| Pfizer | 2 | $39 |
| Photonicare Inc | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Abbott | 1 | $24 |
| Medtronic | 1 | $22 |
| Genentech USA, Inc. | 1 | $15 |
| Insulet Corporation | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Bavarian Nordic A/s | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$2,285 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 42 | $499 |
| Metformin Hcl | 54 | $477 |
| Levothyroxine Sodium | 48 | $451 |
| Atorvastatin Calcium | 49 | $408 |
| Losartan Potassium | 36 | $357 |
| Famotidine | 17 | $280 |
| Amlodipine Besylate | 40 | $273 |
| Alendronate Sodium | 25 | $183 |
| Lisinopril | 29 | $181 |
| Pantoprazole Sodium | 19 | $169 |
| Metformin Hcl ErMetformin Hcl | 18 | $144 |
| Carvedilol | 16 | $137 |
| Hydrochlorothiazide | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Roanoke
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
- Linda SchneiderHampton$2.1M
- Jennifer BrownMidlothian$1.3M
- Brian McCormickHampton$793K
- Jerome DanielNorth Chesterfield$779K
- Samir AbdelshaheedChesapeake$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.